A Multiple Ascending Dose Study of the mTOR Inhibitor (RAD001) in Combination With R1507 in Patients With Advanced Solid Tumors

NCT00985374 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: RAD001
DRUG: RG1507

Sponsor

Hoffmann-La Roche